Azzad Asset Management Inc /Adv Dr Reddys Laboratories LTD Transaction History

Azzad Asset Management Inc /Adv

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2017 Apr 03, 2024	SELL	$30.11 - $37.72 $780,421 - $977,664	-25,919 Closed	0 $0
Q2 2017 Apr 03, 2024	BUY	N/A	507 Added 2.0%	25,919 $1.09 Billion
Q1 2017 Apr 03, 2024	BUY	N/A	5,808 Added 29.63%	25,412 $1.02 Billion
Q4 2016 Apr 03, 2024	SELL	N/A	-197 Reduced 0.99%	19,604 $888 Million
Q3 2016 Apr 03, 2024	BUY	N/A	3,288 Added 19.91%	19,801 $919 Million
Q2 2016 Apr 03, 2024	BUY	N/A	3,061 Added 22.75%	16,513 $846 Million
Q1 2016 Apr 03, 2024	SELL	N/A	-2,734 Reduced 16.89%	13,452 $608 Million
Q4 2015 Apr 03, 2024	BUY	N/A	333 Added 2.1%	16,186 $749 Million
Q3 2015 Apr 03, 2024	BUY	N/A	1,416 Added 9.81%	15,853 $1.01 Billion
Q2 2015 Apr 03, 2024	BUY	N/A	6,256 Added 76.47%	14,437 $799 Million
Q1 2015 Apr 03, 2024	BUY	N/A	631 Added 8.36%	8,181 $467 Million
Q4 2014 Apr 03, 2024	BUY	N/A	7,550 New	7,550 $381 Million
Q4 2012 Apr 08, 2024	SELL	N/A	-11,026 Closed	0 $0
Q3 2012 Apr 08, 2024	SELL	N/A	-11,963 Reduced 52.04%	11,026 $340 Million
Q2 2012 Apr 08, 2024	SELL	N/A	-443 Reduced 1.89%	22,989 $682 Million
Q1 2012 Apr 08, 2024	SELL	N/A	-243 Reduced 1.03%	23,432 $810 Million
Q4 2011 Apr 08, 2024	SELL	N/A	-838 Reduced 3.42%	23,675 $697 Million
Q3 2011 Apr 08, 2024	BUY	N/A	365 Added 1.51%	24,513 $730 Million
Q2 2011 Apr 08, 2024	SELL	N/A	-114 Reduced 0.47%	24,148 $829 Million
Q1 2011 Apr 08, 2024	SELL	N/A	-1,514 Reduced 5.87%	24,262 $905 Million
Q4 2010 Apr 08, 2024	BUY	N/A	25,776	25,776 $953 Million

245

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.55B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.